Gastric Pacing for Obesity Changes Gut Peptide and Leptin Levels
Gastric electrical pacing in morbidly obese patients altered gut peptide levels (CCK, somatostatin) and reduced leptin, providing a hormonal mechanism for the satiety and weight loss observed with this device.
Quick Facts
What This Study Found
Gastric pacing in morbidly obese patients altered circulating CCK, somatostatin, and leptin levels, providing a neuroendocrine mechanism for the satiety and weight loss effects of this device.
Key Numbers
How They Did This
Clinical trial measuring plasma gut peptides (CCK, somatostatin, GLP-1, PYY) and leptin in morbidly obese patients before and during gastric electrical pacing treatment.
Why This Research Matters
Understanding that gastric pacing works through hormones, not just mechanics, opens the door to optimizing the electrical parameters for maximal appetite-suppressing peptide release.
The Bigger Picture
Electrical stimulation of the gut can modulate appetite hormones — a concept that bridges neurostimulation and endocrinology for obesity treatment.
What This Study Doesn't Tell Us
Small clinical study. Cause-effect relationship between peptide changes and weight loss not definitively established. The specific pacing parameters affecting each peptide not characterized.
Questions This Raises
- ?Can pacing parameters be optimized for maximal GLP-1/PYY release?
- ?Does the hormonal response predict weight loss success?
- ?Could non-invasive gastric stimulation achieve similar peptide changes?
Trust & Context
- Key Stat:
- Hormonal mechanism Gastric pacing changed appetite hormone levels — it works through the gut's peptide signaling system, not just by making the stomach smaller
- Evidence Grade:
- Moderate evidence from a clinical study with objective hormonal measurements in treated patients.
- Study Age:
- Published in 2003. Gastric electrical stimulation for obesity continues to be developed with improved understanding of its hormonal effects.
- Original Title:
- Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.
- Published In:
- Obesity research, 11(12), 1456-62 (2003)
- Authors:
- Cigaina, Valerio, Hirschberg, Angelica L
- Database ID:
- RPEP-00807
Evidence Hierarchy
Frequently Asked Questions
How does a stomach pacemaker help with weight loss?
It sends electrical signals to the stomach that change appetite hormone levels — reducing hunger hormones and altering satiety signals. It's not just about stomach size but about rewiring the hormonal appetite system.
Is this different from gastric bypass?
Yes — it's less invasive (no cutting/rearranging). It works by modulating the stomach's electrical and hormonal activity rather than physically restricting or bypassing the digestive tract.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00807APA
Cigaina, Valerio; Hirschberg, Angelica L. (2003). Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.. Obesity research, 11(12), 1456-62.
MLA
Cigaina, Valerio, et al. "Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin.." Obesity research, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Gastric pacing for morbid obesity: plasma levels of gastroin..." RPEP-00807. Retrieved from https://rethinkpeptides.com/research/cigaina-2003-gastric-pacing-for-morbid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.